Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use

Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use

Abstract Background We use a novel, longitudinal approach to describe average time spent in opioid use disorder (OUD) cascade of care stages for people with HIV (PWH) and with OUD, incorporating four definitions of treatment retention. Using this approach, we describe the impact of cocaine or hazard...

Full description

Bibliographic Details
Main Authors: Jarratt D. Pytell, Anthony T. Fojo, Jeanne C. Keruly, LaQuita N. Snow, Oluwaseun Falade-Nwulia, Richard D. Moore, Geetanjali Chander, Catherine R. Lesko
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Addiction Science & Clinical Practice
Subjects:
Opioid use disorder
Retention
Polysubstance use
Buprenorphine
Online Access:https://doi.org/10.1186/s13722-023-00408-8

Internet

https://doi.org/10.1186/s13722-023-00408-8

Similar Items